AMANDA BEASLEY: Open Payments
NPI 1619125861 · LEXINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$586 in 28 payments from 10 companies in 2025. Trend: 2023 $274 · 2024 $302 · 2025 $586
Food & beverage: $586
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $139 |
| ABBVIE INC. | 7 | $130 |
| Lilly USA, LLC | 1 | $119 |
| Otsuka America Pharmaceutical, Inc. | 3 | $73 |
| AstraZeneca Pharmaceuticals LP | 3 | $44 |
| PFIZER INC. | 1 | $19 |
| Exact Sciences Corporation | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
| Amgen Inc. | 1 | $14 |
Products named: ZEPBOUND, VRAYLAR, REXULTI, Wegovy, Ozempic, QULIPTA, AIRSUPRA, PREVNAR 20.
Industry payments across NC — which companies pay providers there.
